Scordis, Phil (UCB 201209 Director of Informatics) |
IT manager |
UCB (Group) |
Belgium |
Scots-Knight, Denise (formerly Pollard-Knight) (Mereo BioPharma 201507 CEO before Managing Partner at Phase4 Ventures) |
Chief Executive Officer (CEO) |
Mereo BioPharma Group Ltd. |
United Kingdom (GB) |
Scott, Kalina (Polyphor 201706– CFO before Bank am Bellevue + UBS + KPMG) |
Chief Financial Officer (CFO) |
Polyphor Ltd. (SIX: POLN) |
Switzerland |
Scott, Nerida (JnJ 202009 Head JnJ Innovation EMEA) |
Business Development Manager / Strategy Manager |
Johnson & Johnson (JnJ) (Group) |
United Kingdom (GB) |
Scott, Ronald (Ron) (Basilea 201212–201804 CEO before COO before CFO RETIRED 2/18 proposed for Board) |
Chief Executive Officer (CEO) |
Basilea (Group) |
Switzerland |
Scriba, Jürgen (Advalytix co-founder) |
n. a. |
Danaher (Group) |
Germany |
Searle, Susan (Imperial Innovation 200511 CEO) |
Chief Executive Officer (CEO) |
Touchstone Innovations (Group) |
United Kingdom (GB) |
Sebald, Walter |
n. a. |
University of Würzburg |
Germany |
Sebastian, Dirk (Ganymed Pharmaceuticals AG 201309 CFO + COO) |
Chief Financial Officer (CFO) |
Astellas (Group) |
Germany |
Sebhatu, Jared (German Accelerator Life Sciences 201604 Program Director Germany before VDI) |
Business Development Manager / Strategy Manager |
digital health transformation eG (dht) |
Germany |
Sedgwick, Jonathon (Boehringer 201710 VP + Global Head Cancer Immunology + Immune Modulation Research) |
Research & Development Manager |
Boehringer Ingelheim (Group) |
Germany |
Seeberger, Peter H. (MPI of Colloids and Interfaces 2009– Director before ETH Zurich Prof before MIT Prof) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
Seefeldt, Christian H. (MeVis Medical Solutions 200901–201009 CFO resigned 201009 before Saperion AG + Haitec AG) |
Chief Financial Officer (CFO) |
Varian Medical Systems (Group) |
Germany |
Seegers, Christian (Berlin (govt) 201111 Senior Investment Manager Life Science at IBB Beteiligungsges) |
Investment Manager |
Berlin (govt region) |
Germany |
Seehofer, Horst (Germany (govt) 200809 Minister of Agriculture) |
Minister |
Germany (govt) |
Germany |
Seewald, Michael (Bayer HealhCare 200506) |
n. a. |
Bayer (Group) |
Germany |
Seewald, Sascha (Caterna GmbH 201101 Managing Director) |
Managing Director |
Caterna Vision GmbH |
Germany |
Segeberg, Friederike (Merck (DE) 202002 Head Media Relations) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
Segerros, Andreas (Sunstone Capital 201502 Partner) |
Partner (venture partner) |
Eir Ventures |
Sweden |
Seghezzi, Graziano (Sofinnova Partners 200806 Partner) |
Partner (venture partner) |
Sofinnova (Group) |
France |
Sehlmeyer, Rasa (HighQu GmbH 201504 Managing Director) |
Managing Director |
HighQu GmbH |
Germany |
Seibert, Daniel (Life Technologies 201105 CFO of Geneart AG LEFT Geneart BEFORE 7/12) |
Chief Financial Officer (CFO) |
Thermo Fisher (Group) |
Germany |
Seibert, Gloria Sophia (Temedica 202001 Managing Director + Co-Founder) |
Managing Director |
Temedica GmbH |
Germany |
Seidel, Guido (Wacker 202007 Managing Director of Wacker Biotech GmbH + Head of Biopharma Business) |
Managing Director |
Wacker (Group) |
Germany |
Seidel, Mathias (Denk Pharma 201611 Business Development) |
Business Development Manager / Strategy Manager |
Denk Pharma (Group) |
Germany |
Seidel, Uwe (XotonicsMED GmbH 201607 Managing Director) |
Managing Director |
XotonicsMED GmbH |
Germany |
Seidel, Wolfgang (Advigen 201201 before Innogenetics 2005–2009 VP BusDev + Bayer Pharma 1981–2004) |
Consultant (economic/technology) |
Advigen Dr. Wolfgang Seidel Biotechnology Consulting |
Germany |
Seidelmann, Oliver (Chiroblock GmbH 201109 Managing Director + co-founder) |
Managing Director |
ChiroBlock GmbH |
Germany |
Seidl, Gerd (Bayer Innovation GmbH 200606) |
n. a. |
Bayer (Group) |
Germany |
Seidler, Jörg (SGS 201110 Project Scientist at SGS M-Scan GmbH) |
Laboratory Manager (industry) |
SGS (Group) |
Germany |
Seifert, Martin (Genomatix 201103 CEO existent before 200808 VP Business Development + Consulting) |
Chief Executive Officer (CEO) |
Genomatix Software (Group) |
Germany |
Seifert, Roland (MHH 201110 Professor + Director of Institute of Pharmacology) |
Professor |
MHH (Hanover Medical School / Medizinische Hochschule Hannover) |
Germany |
Seipelt, Joachim (Nuvonis Technologies 201803 Head of Business Development) |
Business Development Manager / Strategy Manager |
Nuvonis Technologies GmbH |
Austria |
Seizinger, Bernd R. (GPC Biotech 199810– CEO before BMS Pharma Research Institute) |
Chief Executive Officer (CEO) |
HOPP Group (family of Dietmar Hopp) |
Germany |
Sekhar, P. Chandra (Brand 200705 Consultant Indian Contact) |
n. a. |
Brand (Group) |
Germany |
Sekhri, Paul J. (eGenesis 201901– CEO before Lycera + Sanofi + Teva + TPG Biotech + Cerimon + Ariad + Sprout) |
Chief Executive Officer (CEO) |
eGenesis Inc. |
United States (USA) |
Selbach, Matthias (Helmholtz 201402– Professor for Proteomics Research at MDC Berlin) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Selick, Barry (Threshold Pharmaceuticals 200607 CEO) |
Chief Executive Officer (CEO) |
Threshold Pharmaceuticals Inc. (Nasdaq: THLD) |
United States (USA) |
Selvaraju, Raghuram (Ram) (Relief Therapeutics 202010 Board Chairman) |
Board member, non-executive |
Relief Therapeutics (Group) |
Switzerland |
Selzer, Sebastian (PS Biotech GmbH 201305 Managing Director + Co-Founder) |
Managing Director |
PS Biotech GmbH |
Germany |
Semmler, Hans-Christian (HCS Beteiligungsgesellschaft 201309 Managing Director) |
Managing Director |
HCS Beteiligungsgesellschaft mbH |
Germany |
Sen, Michael (Siemens 201711 Manamgent Board Member) |
Board member, executive |
Siemens (Group) |
Germany |
Senatore, Carmine (Univ Geneva 201606 Prof in Dept of Quantum Matter Physics) |
Professor |
University of Geneva (Université de Genève, UNIGE) |
Switzerland |
Senequier, Dominique (Adrian 201309 CEO) |
Chief Executive Officer (CEO) |
Ardian (Group) |
France |
Senker, Jürgen (Univ Bayreuth 201802– Prof of Inorganic Chemistry + Head of Northern Bavarian NMR Centre) |
Professor |
University of Bayreuth |
Germany |
Senne, Wolfgang (Oridis Biomarkers 201107 CEO LEFT BEFORE 5/12 before CFO before GeneScan + Carl Zeiss Medical) |
Chief Executive Officer (CEO) |
Oridis Biomarkers GmbH |
Austria |
Serrano, Pablo (BPI 201301– Head Biotechnology / RnD before BIO Deutschland before Biocom AG) |
n. a. |
BPI (Bundesverband der Pharmazeutischen Industrie e. V.) |
Germany |
Serrar, Karim |
n. a. |
GoingPublic Media AG (FSE: WKN 761 210) |
Germany |
Serre, Alexander (Cytosurge 201802 Sales + Marketing Director) |
Sales Manager / Marketing Manager |
Cytosurge AG |
Switzerland |
Servais, Gaetan (Noshaq 202101 CEO) |
Chief Executive Officer (CEO) |
Noshaq S.A. |
Belgium |
Seulberger, Harald (BASF Plant Science 200503) |
n. a. |
BASF (Group) |
Germany |
Seuster, Moritz (Biocrates 201909– Co-CEO + CFO before 201906 CFO + 201903– Managing Director of Metanomics Health GmbH) |
Chief Financial Officer (CFO) |
Biocrates (Group) |
Austria |
Sevenard, Dmitry (Hansa Fine Chemicals 201212 Managing Director) |
Managing Director |
Hansa Fine Chemicals GmbH |
Germany |
Severinghaus, Carl (Tecan 2007– Senior VP Direct Sales joined Tecan US 1991) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Switzerland |
Severino, Michael E. (AbbVie 201603 EVP + CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
AbbVie (Group) |
United States (USA) |
Seymour, Albert (Shire 201401 Head of Discovery Biology + Translational Research) |
Research & Development Manager |
Takeda (Group) |
Ireland, Republic of |
Shadday, Peter (Breath Therapeutics 201810– CCO before Vertex + Lundbeck + Gilead + Novartis) |
Chief Commercial Officer (CCO) |
Zambon (Group) |
Netherlands |
Shahani, Ranjit (Novartis 201304 Managing Director of Novartis India Ltd) |
Managing Director |
Novartis (Group) |
India |
Shahidi, Mehdi (Boehringer 201903– CMO before Global Head Oncology joined in 2005) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Germany |
Shahzad, Aamir (EUSTM 201307 President) |
President/Director/Head Business Group/Unit/Division |
European Society for Translational Medicine (EUSTM) |
Austria |
Shakesheff, Kevin (Univ Nottingham 201405 Professor + CSO + Founder of Locate Therapeutics) |
Professor |
University of Nottingham |
United Kingdom (GB) |
Shalmi, Michael (Novo Group 201702 Managing Director of Large Investment at Novo A/S) |
Managing Director |
Novo Group (Group) |
Denmark |
Shana, May (Beiersdorf 201807 Senior Corporate VP RnD) |
Research & Development Manager |
Beiersdorf (Group) |
Germany |
Shannon, James S. (GSK 201205– CMO before Board Member several firms before 14y at Novartis until 2008) |
Chief Medical Officer (CMO) |
GlaxoSmithKline (GSK) (Group) |
United Kingdom (GB) |
Shannon, Timothy M. (Canaan Partners 2009– General Partner before CuraGen + Bayer HealthCare) |
General Partner (venture partner) |
Canaan Partners (Group) |
United States (USA) |
Sharei, Armon (SQZ Biotech 201512 CEO + Founder) |
Chief Executive Officer (CEO) |
SQZ Biotechologies (US) |
United States (USA) |
Sharma, Arya M. |
n. a. |
Humboldt University Berlin |
Germany |
Sharma, Panna (Lantern Pharma 202008 CEO before Cancer Genetics 201402 CEO) |
Chief Executive Officer (CEO) |
Lantern Pharma Inc. (LTRN) |
United States (USA) |
Shasserre, Christina (Eurofins 201401– Head Pharma BioAnalytical Services before Merck Millipore DDS + Sigma-Aldrich) |
President/Director/Head Business Group/Unit/Division |
Eurofins (Group) |
United States (USA) |
Sheehy, Tim (Promega 201211 Genomics Marketing Director) |
Sales Manager / Marketing Manager |
Promega (Group) |
United States (USA) |
Sheets, Ellen E. (Qiagen 201007– CMO before Predictive Biosciences CMO before Hologic CMO) |
Chief Medical Officer (CMO) |
Qiagen (Group) |
United States (USA) |
Sheffery, Michael (Mike) (OrbiMed 201112 Founding Partner) |
Partner (venture partner) |
OrbiMed (Group) |
United States (USA) |
Sheldon, Jonathan (Qiagen 202001 SVP Qiagen Digital Insights before InforSense 200408) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Germany |
Sheldon, Kate (Courtagen 201206 Director of Product Development) |
Research & Development Manager |
Courtagen Life Sciences Inc. |
United States (USA) |
Shem-Tov, Kathrin (Develogen 200411–200706– Manager Corporate Affairs) |
n. a. |
Evotec (Group) |
Germany |
Sheridan, Gerry (Molecular Health 201607– CFO based in Boston before Seno Medical + GDC Technics) |
Chief Financial Officer (CFO) |
Molecular Health (Group) |
Germany |
Sheridan, Jonathan M. (Biomax Informatics 201410– CEO of US subsidiary before Integrated Genomics + HGT + Epicentre) |
Chief Executive Officer (CEO) |
|
|
Sherif, Riad (Oculis 201801– CEO before Novartis Area President EMEA at Alcon) |
Chief Executive Officer (CEO) |
Oculis (Group) |
Switzerland |
Sherman, Matthew (Triangle Research Labs 201606 Managing Director) |
Chief Executive Officer (CEO) |
Lonza (Group) |
United States (USA) |
Shetty, Roshan (Anasys Instruments 201804 Co-Founder + former CEO) |
Company Founder |
Bruker (Group) |
United States (USA) |
Shi, Gongyi (Bruker 201206 Director Scientific Affairs at Microbiology Business of Bruker Daltonics) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
Shi, Victor (Qiagen Asia 200702) |
n. a. |
Qiagen (Group) |
Germany |
Shin, Nam (Nexus Dx 201805 CEO) |
Chief Executive Officer (CEO) |
SphingoTec (Group) |
United States (USA) |
Shine, Dan (Thermo Fisher 201304 President of Chromatography + Mass Spectrometry Business) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
Shoffner, John |
n. a. |
|
|
Shortland, Tim (Quayle Munro 201306 Managing Director) |
Managing Director |
Quayle Munro Ltd. |
United Kingdom (GB) |
Shuster, Alexandr (Inbio Ventures 201308 President) |
President/Director/Head Business Group/Unit/Division |
Pharmstandard (Group) |
Russian Federation |
Sidler, Michael (Redalpine 201210) |
n. a. |
Redalpine Venture Partners AG |
Switzerland |
Siebenkotten, Gregor (amaxa Co-founder) |
Company Founder |
Lonza (Group) |
Germany |
Sieber, Stephan (TU Munich 202007 Professor) |
Professor |
Technical University Munich (TU München, TUM) |
Germany |
Sieberer, Thomas (Biocrates 2003) |
n. a. |
Biocrates (Group) |
Austria |
Siegel, Oliver (Affiris 201506– CEO joined 201409 as COO before Rothschild in London + HSBC plc) |
Chief Executive Officer (CEO) |
Affiris AG |
Austria |
Sieker, Olaf (MeVis Medical 2007Q3–200812 CFO left 1/09) |
Chief Financial Officer (CFO) |
Varian Medical Systems (Group) |
Germany |
Sieler, Miguel (Neovacs 201310 CEO before Bayer France CEO at Bayer since 1975) |
Chief Executive Officer (CEO) |
Neovacs (Group) |
France |
Sieper, Albrecht (Elementar 201701 Managing Director of Elementar Analystensysteme GmbH) |
Managing Director |
Elementar (Group) |
Germany |
Sieper, Hans-Peter (Elementar 201701 Managing Director of Elementar Analystensysteme GmbH) |
Managing Director |
Elementar (Group) |
Germany |
Siesel, Peter (Tecan 201106 VP Sales + Marketing Tecan US) |
Sales Manager / Marketing Manager |
Tecan (Group) |
United States (USA) |
Sietzema, Sietze (Lactotronic 201807 Founder) |
Company Founder |
Bruker (Group) |
Netherlands |
Sievers, Stephan (NuVasive 200909 Managing Director NuVasive Europe GmbH) |
Managing Director |
NuVasive (Group) |
Germany |
Sievert, Dominik (Inveox GmbH 201702– Managing Director + Co-Founder) |
Managing Director |
Inveox (Group) |
Germany |